Oncimmune Holdings (LSE:ONC) EBIT : £-3.26 Mil (TTM As of Aug. 2024)

Oncimmune Holdings EBIT Chart

Oncimmune Holdings Annual Data
	Trend	May15	May16	May17	May18	May19	May20	May21	May22	Aug23	Aug24
EBIT		Get a 7-Day Free Trial					-9.47	-5.22	-8.59	-5.41	-3.26

Oncimmune Holdings Semi-Annual Data
	Nov14	May15	Nov15	May16	Nov16	May17	Nov17	May18	Nov18	May19	Nov19	May20	Nov20	May21	Nov21	May22	Feb23	Aug23	Feb24	Aug24
EBIT	Get a 7-Day Free Trial															-4.17	-3.47	-1.94	-0.76	-2.51

Competitive Comparison of Oncimmune Holdings's EBIT

For the Biotechnology subindustry, Oncimmune Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncimmune Holdings's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncimmune Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Oncimmune Holdings's EV-to-EBIT falls into.

Oncimmune Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Aug. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-3.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncimmune Holdings  (LSE:ONC) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Oncimmune Holdings's annualized ROC % for the quarter that ended in Aug. 2024 is calculated as:

where

Note: The Operating Income data used here is two times the semi-annual (Aug. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Oncimmune Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Aug. 2024 is calculated as:

where Working Capital is:

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Aug. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Oncimmune Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncimmune Holdings EBIT Related Terms

Thank you for viewing the detailed overview of Oncimmune Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncimmune Holdings Business Description